Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc.

25.67
EUR
0.00
(0.00%)
-3.79EPS
2.57BMarket Cap
Nov 11Next Earn

Latest Stock Split

Feb 11, 2019

1:15

For every 15 shares held, investors received 1.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Feb 11, 2019
    Before—
    Split ratio1:15
    After—
    Reverse
  2. Mar 10, 2008
    Before—
    Split ratio1:12
    After—
    Reverse

About Celldex Therapeutics, Inc. stock splits

Celldex Therapeutics, Inc. (GETTEX:TCE2) operates in the Biotechnology industry.

Celldex Therapeutics, Inc. company overview

When did Celldex Therapeutics, Inc. stock split?

Celldex Therapeutics, Inc.'s most recent stock split was on February 11, 2019. It was a 1-for-15 reverse split, so shareholders received 1 share for every 15 they held.

What is Celldex Therapeutics, Inc.'s stock split history?

Celldex Therapeutics, Inc. (GETTEX:TCE2) has split its stock 2 times: a 1-for-12 reverse split on March 10, 2008 and a 1-for-15 reverse split on February 11, 2019.

How many times has Celldex Therapeutics, Inc. stock split?

Celldex Therapeutics, Inc. has split its stock 2 times. This history records 2 reverse splits between March 10, 2008 and February 11, 2019.

What is a reverse stock split?

A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Celldex Therapeutics, Inc.'s 1-for-15 reverse split on February 11, 2019, every 15 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.

Will Celldex Therapeutics, Inc. split its stock again?

Celldex Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on February 11, 2019, 7 years ago. Companies announce splits in advance, and any new GETTEX:TCE2 split will appear on this page.